Synapse - Head and Neck Service

Results (58)

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

Editorial

Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2024)

Fulltext@MSK | Save

Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer

Meeting Abstract

Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2023)

Fulltext@MSK | Save

Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients

Journal Article

Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2023)

Fulltext@MSK | Save

Loss of CDKN2A/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma

Journal Article

Dogan, S.; Xu, B.; Rana, S.; Chen, H.; Ghossein, R. A.; Berger, M. F.; Ho, A. L.; Katabi, N.
Modern Pathology (2023)

Fulltext@MSK | Save

Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy

Journal Article

Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): A randomised, double-blind, placebo-controlled, multicentre, phase 2 trial

Journal Article

Sherman, E. J.; Harris, J.; Bible, K. C.; Xia, P.; Ghossein, R. A.; Chung, C. H.; Riaz, N.; Gunn, G. B.; Foote, R. L.; Yom, S. S.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)

Meeting Abstract

Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A pilot study of durvalumab (MEDI4736) with tremelimumab in combination with image-guided stereotactic body radiotherapy in the treatment of metastatic anaplastic thyroid cancer

Journal Article

Lee, N. Y.; Riaz, N.; Wu, V.; Brinkman, T.; Tsai, C. J.; Zhi, W.; Fetten, J.; Ho, A.; Wong, R. J.; Ghossein, R.; more...
Thyroid (2022)

Fulltext@MSK | Save